Neuralgia  >>  Palexia RP (tapentadol extended release)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Palexia RP (tapentadol extended release) / Assertio, J&J, Grunenthal, Collegium Pharma
NCT01124617: A Phase 2 Study of Tapentadol Extended-Release (JNS024ER) ) in Japanese Participants With Chronic Pain Due to Diabetic Neuropathic Pain or Postherpetic Neuralgia

Completed
2
91
Japan
Tapentadol, JNS024ER, Placebo
Janssen Pharmaceutical K.K.
Pain, Diabetic Neuropathies, Neuralgia, Postherpetic Neuralgia
04/11
04/11

Download Options